Value of serum CEA and CA19-9 dynamic changes and trajectory modeling in prognosis assessment for non-small cell lung cancer. [PDF]
Huang J +6 more
europepmc +1 more source
Dynamics of Serum CA19-9 in Patients Undergoing Pancreatic Cancer Resection
Background: Carbohydrate antigen (CA) 19-9 is an established perioperative prognostic biomarker for pancreatic ductal adenocarcinoma (PDAC). However, it is unclear how CA19-9 monitoring should be used during postoperative surveillance to detect ...
Daamen, L A +8 more
core
Diagnostic and Prognostic Value of CA19-9 in Pancreatic Tumors: A Retrospective Study. [PDF]
Almbaidin FA +6 more
europepmc +1 more source
Diagnostic value of combined serum CEA and CA19-9 in colorectal cancer A meta-analysis. [PDF]
Zhou L +6 more
europepmc +1 more source
Diagnostic Performance of Platelet-to-Lymphocyte Ratio and CA19-9 Added to EUS-FNA for Solid Pancreatic Lesions: A Single-Center Retrospective Study. [PDF]
Liu S, Hu C, Fan Y, Liu L, Hu Y.
europepmc +1 more source
Serum HMGB1 and CA19-9 are independently associated with pulmonary cavity formation in patients with non-tuberculous mycobacterial pulmonary disease. [PDF]
Zhang Y, Jiang Y.
europepmc +1 more source
Hepatocellular jaundice with abnormally high CA19-9: A case report. [PDF]
Cui Y, Zhang Y, Huang Y, Feng R, Chen Q.
europepmc +1 more source
A rare case of pulmonary sequestration with elevated CA19-9 levels. [PDF]
Zhang MM, Jin X, Li J, Wu X, Wang C.
europepmc +1 more source
Development and validation of a prognostic nomogram incorporating preoperative NLR, CEA and CA19-9 for overall survival in colorectal cancer. [PDF]
Shi B +8 more
europepmc +1 more source

